Competing interests
RS, Cancer
ONCOLOGY, CANCER
WPY has advisory roles for Abbvie/Genentech, Amgen, Astra Zeneca, Bristol-Myers Squibb, Ipsen and Novartis. He is part of the Speakers’ Bureau for Bayer, Eisai, Lilly, MSD Oncology, Sanofi/Aventis, Taiho Pharmaceuticals. He has received funding for travels and accommodations from Pfizer. RS (Raghav Sundar) has received honoraria from Bristol-Myers Squibb, Lilly, Roche, Taiho, Astra Zeneca, DKSH and MSD; has advisory activity with Bristol-Myers Squibb, Merck, Eisai, Bayer, Taiho, Novartis, MSD and Astra Zeneca; received research funding from MSD and Paxman Coolers; and has received travel grants from Astra Zeneca, Eisai, Roche and Taiho Pharmaceutical. Financial disclosures: RS is supported by the National Medical Research Council (NMRC) (NMRC/TA/0014/2020). AW has research funding from Otsuka Pharmaceuticals, and has advisory roles for Pfizer, Novartis, Eisai, and Astra Zeneca. JSL has advisory and consulting activity with Pfizer, MSD, AZD, Novartis, Roche, Eisai and DKSH. JSL has received funding for speaker engagement from Pierre Fabre and Eisai. She has received travel grants from Astra Zeneca and Pfizer. She has research grants from CTI biopharma. DST has received honoraria and consulting fees from Astra Zeneca, Eisai, MSD, Roche, GSK and Bayer. He has grant support from National Medical Research Council Singapore and Pangestu Family Foundation Gynaelogical Cancer Research Fund. He has received funding for travel and accommodations from Astra Zeneca, Bayer, Roche and Clovis. RS (Ross Soo) is on the Advisory Board of Amgen, Astra Zeneca, Bayer, BMS, Boehringer Ingelheim, Janssen, Lilly, Merck, Merck Serono, Novartis, Pfizer, Puma, Roche, Taiho, Takeda, Yuhan. He has Research grant with Astra Zeneca and Boehringer Ingelheim. SCL receives Grant support and has Research Collaborations from Pfizer, Eisai, Taiho, ACT Genomics, Bayer, MSD, Adagene. She is on the Advisory Board and has had Speaker Invitations from Pfizer, Novartis, Astra Zeneca, ACT Genomics, Eli Lilly, MSD, Roche, Eisai and Daiichi-Sankyo. She has received Conference support from Amgen, Pfizer, Roche. CEC has received honoraria from Astra Zeneca and Roche/Genentech. She has a consulting or advisory role with Guardant Health AMEA. She has received travel grants from Taiho Pharmaceutical. JL and GBC declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.